ASND Q1 2026 Earnings Miss on EPS Amid Ongoing Investment Cycle Monte Rosa Therapeutics Inc GLUE Q1 2026 Earnings WiderthanExpected Loss Compounds Investor Caution Iovance Biotherapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Momentum CYTK Q1 2026 Earnings Narrower Loss Boosts Investor Confidence but Stock Falters OEC Q1 2026 Earnings EPS Misses Estimates Sharply Stock Rises Despite Loss